𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Removal and inactivation of hepatitis A virus during manufacture of urokinase from human urine

✍ Scribed by In Seop Kim; Yong Woon Choi; Sung Rae Lee; Yong Kang; Kyung Myung Lee; Dae Han Park; Han Sang Woo; Soungmin Lee

Publisher
The Korean Society for Biotechnology and Bioengineering
Year
2002
Tongue
English
Weight
186 KB
Volume
7
Category
Article
ISSN
1226-8372

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Removal/neutralization of hepatitis A vi
Removal/neutralization of hepatitis A virus during manufacture of high purity, solvent/detergent factor VIII concentrate
✍ Stanley M. Lemon; Paula C. Murphy; Andrew Smith; Jinsheng Zou; John Hammon; Step πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 559 KB

## Abstract Recent reports have suggested an increased risk of type A viral hepatitis in hemophilic patients treated with high purity factor VIII concentrates prepared using ion exchange chromatography coupled with solvent/detergent treatment for in‐activation of viruses. To determine the capacity

Virus safety of human immunoglobulins: E
Virus safety of human immunoglobulins: Efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure
✍ Thomas Nowak; Jens-Peter Gregersen; Ulrich Klockmann; Larry Bill Cummins; Dr. Jo πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 720 KB

## Abstract Human immunoglobulins are plasma derivatives with a low risk of transmitting viral infections. To the present, no proven case of human immunoglobulins transmitting human immunodeficiency viruses has been reported. However, there have been a few reports on the transmission of hepatitis C

Inactivation of 12 viruses by heating st
Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine
✍ Dr. P. N. Lelie; H. W. Reesink; C. J. Lucas πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

The efficacy of two heating cycles (90 sec at 103 O C and 10 hr at 65 "C) used during manufacture of a plasma-derived hepatitis-B vaccine was validated for the inactivation of 12 virus families. A period of 15 min warming up to 65 O C had already completely inactivated representatives of nine virus

Inactivation of 1015 chimpanzee-infectio
Inactivation of 1015 chimpanzee-infectious doses of hepatitis B virus during preparation of a heat-inactivated hepatitis B vaccine
✍ Dr. P. N. Lelie; H. W. Reesink; J. Niessen; B. Brotman; A. M. Prince πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 396 KB

The safety of a plasma-derived hepatitis-B vaccine inactivated by two heating steps (90 sec at 103 "C followed by 10 hr pasteurization at 65 "C) was validated in chimpanzees; 1 O3 chimpanzee-infectious doses (CID,,) of hepatitis-B virus (HBV), subjected to the purification steps during production of